Trulieve Cannabis Corp. (TRLV) stock
TRLVNYSEMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3033% below fair value
$10.02−0.05 (-0.50%)
Close on Nov 18, 2026Market cap $1.93BP/E –Yield –
Trulieve Cannabis operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Trulieve Cannabis's operating income for the twelve months ending Jun 30, 2026 was -$277.26M, down 415.5% year over year. For fiscal 2025 it was $143.50M, up 46.8% from the year before. The highest annual figure on record is $218.30M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $143.50M | +46.8% |
| FY2024 | Dec 31, 2024 | $97.78M | – |
| FY2023 | Dec 31, 2023 | -$221.61M | -541.8% |
| FY2022 | Dec 31, 2022 | $50.17M | -75.4% |
| FY2021 | Dec 31, 2021 | $204.05M | -6.5% |
| FY2020 | Dec 31, 2020 | $218.30M | +92.7% |
| FY2019 | Dec 31, 2019 | $113.27M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$370.52M | -804.0% |
| Q1 FY2026 | Mar 31, 2026 | $35.73M | +7.2% |
| Q4 FY2025 | Dec 31, 2025 | $15.30M | +1069.5% |
| Q3 FY2025 | Sep 30, 2025 | $42.24M | +6734.6% |
| Q2 FY2025 | Jun 30, 2025 | $52.63M | +5.8% |
| Q1 FY2025 | Mar 31, 2025 | $33.33M | -27.7% |
| Q4 FY2024 | Dec 31, 2024 | $1.31M | -95.5% |
| Q3 FY2024 | Sep 30, 2024 | $618.00K | -97.4% |
| Q2 FY2024 | Jun 30, 2024 | $49.75M | – |
| Q1 FY2024 | Mar 31, 2024 | $46.10M | +168.7% |
| Q4 FY2023 | Dec 31, 2023 | $29.18M | +460.5% |
| Q3 FY2023 | Sep 30, 2023 | $23.34M | – |
| Q2 FY2023 | Jun 30, 2023 | -$291.29M | -802.3% |
| Q1 FY2023 | Mar 31, 2023 | $17.15M | -41.2% |
| Q4 FY2022 | Dec 31, 2022 | $5.21M | – |
| Q3 FY2022 | Sep 30, 2022 | -$27.34M | -141.2% |
| Q2 FY2022 | Jun 30, 2022 | $41.47M | -45.6% |
| Q1 FY2022 | Mar 31, 2022 | $29.17M | -59.8% |
| Q4 FY2021 | Dec 31, 2021 | -$11.09M | -117.4% |
| Q3 FY2021 | Sep 30, 2021 | $66.28M | +11.4% |
| Q2 FY2021 | Jun 30, 2021 | $76.30M | +45.4% |
| Q1 FY2021 | Mar 31, 2021 | $72.56M | +70.7% |
| Q4 FY2020 | Dec 31, 2020 | $63.84M | – |
| Q3 FY2020 | Sep 30, 2020 | $59.47M | – |
| Q2 FY2020 | Jun 30, 2020 | $52.48M | – |
| Q1 FY2020 | Mar 31, 2020 | $42.51M | – |
See a number that looks wrong?